Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2 antigen for adaptive immune response instigation against type 2 diabetes
<h3>Introduction</h3><p dir="ltr">Diabetes mellitus (DM) is recognized as one of the oldest chronic diseases and has become a significant public health issue, necessitating innovative therapeutic strategies to enhance patient outcomes. Traditional treatments have provided...
محفوظ في:
| المؤلف الرئيسي: | Abbas Khan (5141000) (author) |
|---|---|
| مؤلفون آخرون: | Muhammad Ammar Zahid (18123775) (author), Anwar Mohammad (8383539) (author), Abdelali Agouni (181926) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review
حسب: Shahd Abubaker Elamin (22569539)
منشور في: (2025) -
Exploring the Dynamic Interplay of Deleterious Variants on the RAF1–RAP1A Binding in Cancer: Conformational Analysis, Binding Free Energy, and Essential Dynamics
حسب: Abbas Khan (5141000)
منشور في: (2024) -
Novel Federated Decision Making for Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients
حسب: AlSereidi, Abeer
منشور في: (2022) -
Federal Multi Criteria Decision Making Framework in Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients as Case Study
حسب: ALSEREIDI, ABEER
منشور في: (2022) -
Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
حسب: Swapna Thomas (17337925)
منشور في: (2024)